Carbon footprint of a chemotherapy production unit within a hospital pharmacy: Time for green pharmacy.

Date publication

février 2025

Journal

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Auteurs

Membres identifiés du Cancéropôle Est :
Dr KROEMER Marie

Tous les auteurs :
Chabane M, Fagnoni-Legat C, Hosotte C, Jehl-Rave M, Barbier G, Bonnot-Perrin S, Sadeghipour F, Carrez L, Limat S, Kroemer M

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/39989272

Résumé

In the last decade, environmental impact assessment has become a major concern for human activities, which is particularly true for health. The french healthcare sector emits approximately 49 million tons of CO equivalent (COeq) per year, approximately 8% of the total national Green House Gas (GHG) emissions. In this context, assessing the carbon footprint of a resource-consuming unit like the cytotoxic drug production unit (CPU) is essential. The study aimed to assess the carbon footprint of a CPU.

Mots clés

Carbon footprint, Green House Gas, antineoplastic drug, aseptic unit, chemotherapy, compounding unit, cytotoxic drug preparation unit, healthcare, life cycle assessment, medical device, pharmacy

Référence

J Oncol Pharm Pract. 2025 02 24;:10781552251318313